Jump to content

Mephenytoin: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank').
+sd
 
(21 intermediate revisions by 15 users not shown)
Line 1: Line 1:
{{short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 408590253
| verifiedrevid = 459493896
| IUPAC_name = ''5-ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione''
| IUPAC_name = 5-Ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione
| image = Mephenytoin.svg
| image = Mephenytoin.svg
| alt = Structural formula of mephenytoin
| width = 120
| width = 135
| image2 = Mephenytoin 3D spacefill.png
| alt2 = Space-filling model of the mephenytoin molecule
| width2 = 160


<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
| Drugs.com = {{drugs.com|CONS|mephenytoin}}
| Drugs.com = {{drugs.com|CONS|mephenytoin}}
| MedlinePlus = a611020
| MedlinePlus = a611020
| pregnancy_US = C
| pregnancy_US = C
| legal_status =
| routes_of_administration = Oral
| routes_of_administration = Oral


<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| metabolism = [[CYP2C19]]
| elimination_half-life = 7 hours
| elimination_half-life = 7 hours
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| IUPHAR_ligand = 7223
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 50-12-4
| CAS_number = 50-12-4
| ATC_prefix = N03
| ATC_prefix = N03
| ATC_suffix = AB04
| ATC_suffix = AB04
| ATC_supplemental=
| PubChem = 4060
| PubChem = 4060
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
Line 34: Line 45:


<!--Chemical data-->
<!--Chemical data-->
| C=12 | H=14 | N=2 | O=2
| C=12 | H=14 | N=2 | O=2
| molecular_weight = 218.252
| smiles = O=C2N(C(=O)NC2(c1ccccc1)CC)C
| smiles = O=C2N(C(=O)NC2(c1ccccc1)CC)C
| InChI = 1/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)
| InChIKey = GMHKMTDVRCWUDX-UHFFFAOYAK
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)
| StdInChI = 1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)
Line 44: Line 52:
| StdInChIKey = GMHKMTDVRCWUDX-UHFFFAOYSA-N
| StdInChIKey = GMHKMTDVRCWUDX-UHFFFAOYSA-N
}}
}}

<!--
| ATC_supplemental=
| bioavailability=
| metabolism = Cyp 2C19
| excretion =
| legal_status =
-->
'''Mephenytoin''' (marketed as '''Mesantoin''' by Novartis) is a [[hydantoin]], used as an [[anticonvulsant]]. It was introduced approximately 10 years after [[phenytoin]], in the late 1940s. The significant [[metabolite]] of mephenytoin is [[nirvanol]] (5-ethyl-5-phenylhydantoin), which was the first hydantoin (briefly used as a [[hypnotic]]). However, nirvanol is quite toxic and mephenytoin was only considered after other less toxic anticonvulsants had failed. It can cause potentially fatal blood [[dyscrasia]] in 1% of patients.
'''Mephenytoin''' (marketed as '''Mesantoin''' by Novartis) is a [[hydantoin]], used as an [[anticonvulsant]]. It was introduced approximately 10 years after [[phenytoin]], in the late 1940s. The significant [[metabolite]] of mephenytoin is [[nirvanol]] (5-ethyl-5-phenylhydantoin), which was the first hydantoin (briefly used as a [[hypnotic]]). However, nirvanol is quite toxic and mephenytoin was only considered after other less toxic anticonvulsants had failed. It can cause potentially fatal blood [[dyscrasia]] in 1% of patients.


Line 56: Line 58:


==References==
==References==
{{refbegin}}
* ''The Treatment of Epilepsy'' edited by S. D. Shorvon, David R. Fish, Emilio Perucca, W. Edwin Dodson. Blackwell Publishing. 2004. ISBN 0-632-06046-8
* ''The Medical Treatment of Epilepsy'' by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5.
* {{cite book | title = The Treatment of Epilepsy | veditors = Shorvon SD, Fish DR, Perucca E, Dodson WE | publisher = Blackwell Publishing | date = 2004 | isbn = 0-632-06046-8 }}
* {{cite book | title = The Medical Treatment of Epilepsy | vauthors = Resor SR | publisher = Marcel Dekker | date = 1991 | isbn = 0-8247-8549-5 }}
* [http://ctdbase.org/detail.go?type=chem&acc=D008617 The Comparative Toxicogenomics Database: Mephenytoin]
* {{cite web | url = http://ctdbase.org/detail.go?type=chem&acc=D008617 | work = The Comparative Toxicogenomics Database | title = Mephenytoin }}
{{refend}}


{{Anticonvulsants}}
{{Anticonvulsants}}